Fragilex Diagnostic News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Fragilex diagnostic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Fragilex Diagnostic Today - Breaking & Trending Today

Bio-Techne to Acquire Asuragen


Share this article
Share this article
MINNEAPOLIS and AUSTIN, Texas, March 3, 2021  /PRNewswire/ Bio-Techne Corporation (NASDAQ: TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, today announced it has reached an agreement to acquire Asuragen, Inc. for initial consideration of $215 million in cash plus contingent consideration of up to $105 million upon the achievement of certain future milestones.  The transaction will be financed through a combination of cash on hand and an existing revolving line of credit.  Bio-Techne anticipates the acquisition to close in the fourth quarter of its fiscal 2021.
Founded in 2006, Asuragen is headquartered in Austin, Texas and is a leader in the development, manufacturing and commercialization of genetic carrier screening and oncology testing kits.  Asuragen s products leverage proprietary chemistries which can be used on widely availabl ....

United States , Chuck Kummeth , David Clair , Fredrickson Byron , Lynne Hohlfeld , Matt Mcmanus , Exchange Commission , Prnewswire Bio Techne Corporation , American College Of Obstetricians , Corporate Development , Asuragen Inc , Vinson Elkins , Bio Techne Corporation , Techne Corporation , Good Manufacturing Practice , Chief Executive Officer , Fragilex Diagnostic , Carrier Screening , American College , Diagnostics Segment , Exosome Diagnostics , Perella Weinberg Partners , Looking Statements , Private Securities Litigation Reform , Senior Director , Investor Relations ,